US Congress House Bill 3539 (Prior Session Legislation)

---

Spectrum: Bipartisan Bill
Status: Introduced on September 17 2015 - 25% progression, died in committee
Action: 2015-09-17 - Referred to the House Committee on Ways and Means.
Pending: House Ways And Means Committee
Text: Latest bill text (Introduced) [PDF]

Reinvigorating Antibiotic and Diagnostic Innovation Act of 2015 This bill amends the Internal Revenue Code to allow tax credits for 50% of the clinical testing expenses for: (1) infectious disease products that are intended to treat a serious or life-threatening infection, including one caused by an antibacterial or antifungal resistant pathogen or a qualifying pathogen listed by the Department of Health and Human Services as having the potential to pose a serious threat to public health; and (2) in-vitro diagnostic devices that identify in less than four hours the presence, concentration, or characteristics of a serious or life-threatening infection.

Reinvigorating Antibiotic and Diagnostic Innovation Act of 2015

Rep. Charles Boustany [R-LA]	Rep. Mike Thompson [D-CA]	Rep. Erik Paulsen [R-MN]	Rep. John Shimkus [R-IL]
Rep. Gene Green [D-TX]	Rep. Tom Reed [R-NY]	Rep. Anna Eshoo [D-CA]	Rep. Robert Dold [R-IL]
Rep. Lynn Jenkins [R-KS]	Rep. Linda Sanchez [D-CA]	Rep. Ann Kirkpatrick [D-AZ]	Rep. Raul Grijalva [D-AZ]
Rep. Timothy Walz [D-MN]	Rep. Eliot Engel [D-NY]

Date	Chamber	Action
2015-09-17	House	Referred to the House Committee on Ways and Means.
2015-09-17	House	Introduced in House

Type	Source
Summary	https://www.congress.gov/bill/114th-congress/house-bill/3539/all-info
Text	https://www.congress.gov/114/bills/hr3539/BILLS-114hr3539ih.pdf